Call for papers: Emerging biomarkers in oncology research and practice
We are pleased to announce Cancer Cell International is now accepting submissions for a thematic series on 'Emerging biomarkers in oncology research and practice'.
Guest edited by Dr Aejaz Nasir, the series aims to cover cutting-edge developments in the field of oncology and pathology with reference to diagnostic, prognostic, predictive and pharmacodynamics biomarkers.
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.
Associate Editor spotlight
Matteo Fassan
Dr Fassan is Associate Professor of Pathology in the Department of Medicine at the University of Padua. He is a cancer researcher with expertise in the study of molecular pathology of non-neoplastic, pre-neoplastic, and neoplastic lesions of the gastrointestinal tract.
Editorial Board spotlight
Zhenhua Zou
Dr Zou is a Research Fellow at the University of Michigan Medical School, where she studies epigenetic mechanisms in leukemia and retinoblastoma. She received her doctoral degree in cell biology from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences. With long-term focus and interest in cancer areas, she has accumulated expertise in epigenetics, drug target discoveries, and dysfunctional metabolic and immune signaling in cancer stem cells.
2016 Journal Metrics
-
Speed
30 days from submission to first decision
11 days from acceptance to publicationCitation Impact
2.740 - 2-year Impact Factor
2.924 - 5-year Impact Factor
0.897 - Source Normalized Impact per Paper (SNIP)
1.006 - SCImago Journal Rank (SJR)Usage
327,909 Downloads
950.0 Usage FactorSocial Media Impact
73 Mentions
